![](https://www.theregreview.org/wp-content/uploads/2024/07/LD-7-17-2115237708.jpg)
Access Barriers Remain After Abortion Pill Decision
The Court rejected a challenge to FDA approval of mifepristone, but other obstacles could still impede access. In FDA v. Alliance for Hippocratic Medicine, a unanimous U.S. Supreme Court rejected a lawsuit filed by doctors and associations opposing …